Related Party Transactions (Details Narrative) - PELICAN ACQUISITION CORPORATION - USD ($) |
12 Months Ended | |||||||
|---|---|---|---|---|---|---|---|---|
May 05, 2025 |
Apr. 04, 2025 |
Jan. 10, 2025 |
Aug. 22, 2024 |
Jan. 31, 2026 |
Apr. 28, 2025 |
Jan. 31, 2025 |
Aug. 13, 2024 |
|
| Related Party Transaction [Line Items] | ||||||||
| Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period | 375,000 | |||||||
| Founder Shares issued | 2,875,000 | |||||||
| Founder Shares outstanding | 2,875,000 | |||||||
| Debt Instrument, Face Amount | $ 200,000 | $ 500,000 | ||||||
| Outstanding loan balance | $ 0 | $ 200,000 | ||||||
| Due to related party | 10,200 | (0) | $ 250,000 | |||||
| Working capital loans | 1,500,000 | |||||||
| Borrowings | 0 | $ 0 | ||||||
| Administrative Fees Expense | 15,000 | |||||||
| Monthly fee | $ 20,000 | $ 20,000 | ||||||
| Payment to sponsor | 165,806 | |||||||
| Other Prepaid Expense, Current | 65,806 | |||||||
| Retainer payments | 100,000 | |||||||
| Retainer fee | 50,000 | |||||||
| Initial filing fee | 50,000 | |||||||
| Legal fee | $ 100,000 | 160,000 | ||||||
| Outstanding balance | 350,000 | |||||||
| Flat fee | 10,000 | |||||||
| Prepaid Expense and Other Assets | 80,000 | |||||||
| Other Accrued Liabilities, Noncurrent | $ 80,000 | |||||||
| Related party transactions description | On May 5, 2025, the Company engaged Celine to represent it in all corporate and securities compliance matters in connection with its initial business combination and agrees to pay the following fees: (i) an initial retainer fee of $50,000; (ii) $50,000 upon execution of the Business Combination Agreement (BCA) related to the SPAC merger; (iii) $50,000 upon filing Form F-4 with the SEC; (iv) $50,000 upon receipt of SEC comments and providing corresponding responses; and (v) an closing fee of $50,000. As of January 31, 2026, the Company incurred $200,000 in legal fees, of which $100,000 was paid and unpaid $100,000 was included in the accrued expenses on the accompanying balance sheets as of January 31, 2026. | |||||||
| Mr Hui Chen [Member] | ||||||||
| Related Party Transaction [Line Items] | ||||||||
| Due to related party | $ 350,000 | |||||||
| Founder [Member] | ||||||||
| Related Party Transaction [Line Items] | ||||||||
| Issuance of common shares | 2,875,000 | |||||||
| Stock Issued During Period, Value, New Issues | $ 25,000 | |||||||
| Shares Issued, Price Per Share | $ 0.0087 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of expense for administrative fee from service provided, including, but not limited to, salary, rent, or overhead cost. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Face (par) amount of debt instrument at time of issuance. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of the required periodic payments including both interest and principal payments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The carrying amount as of the balance sheet date for the aggregate of other miscellaneous borrowings owed by the reporting entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of cash outflow for fees classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Per share or per unit amount of equity securities issued. No definition available.
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|